| 1 |
Song HY, Shen R, Mahasin H, Guo YN, Wang DG. DNA replication: Mechanisms and therapeutic interventions for diseases. MedComm (2020) 2023;4:e210. [PMID: 36776764 DOI: 10.1002/mco2.210] [Reference Citation Analysis]
|
| 2 |
Ku X, Wang J, Li H, Meng C, Yu F, Yu W, Li Z, Zhou Z, Zhang C, Hua Y, Yan W, Jin J. Proteomic Portrait of Human Lymphoma Reveals Protein Molecular Fingerprint of Disease Specific Subtypes and Progression. Phenomics 2022. [DOI: 10.1007/s43657-022-00075-w] [Reference Citation Analysis]
|
| 3 |
Pezeshki S, Hashemi P, Salimi A, Ebrahimi S, Javanzad M, Monfaredan A. Evaluation of NUF2 and GMNN Expression in Prostate Cancer: Potential Biomarkers for Prostate Cancer Screening. Rep Biochem Mol Biol 2021;10:224-32. [PMID: 34604412 DOI: 10.52547/rbmb.10.2.224] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 4 |
Liu X, Liu Y, Wang Q, Song S, Feng L, Shi C. The Alterations and Potential Roles of MCMs in Breast Cancer. J Oncol 2021;2021:7928937. [PMID: 34475953 DOI: 10.1155/2021/7928937] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 5 |
Zhou J, Wang M, Zhou Z, Wang W, Duan J, Wu G. Expression and Prognostic Value of MCM Family Genes in Osteosarcoma. Front Mol Biosci 2021;8:668402. [PMID: 34239894 DOI: 10.3389/fmolb.2021.668402] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 6 |
Yu S, Wang G, Shi Y, Xu H, Zheng Y, Chen Y. MCMs in Cancer: Prognostic Potential and Mechanisms. Anal Cell Pathol (Amst) 2020;2020:3750294. [PMID: 32089988 DOI: 10.1155/2020/3750294] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 7 |
Xiong DD, Zeng CM, Jiang L, Luo DZ, Chen G. Ki-67/MKI67 as a Predictive Biomarker for Clinical Outcome in Gastric Cancer Patients: an Updated Meta-analysis and Systematic Review involving 53 Studies and 7078 Patients. J Cancer 2019;10:5339-54. [PMID: 31632479 DOI: 10.7150/jca.30074] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 8 |
Jinjia C, Xiaoyu W, Hui S, Wenhua L, Zhe Z, Xiaodong Z, Midie X. The use of DNA repair genes as prognostic indicators of gastric cancer. J Cancer 2019;10:4866-75. [PMID: 31598158 DOI: 10.7150/jca.31062] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 9 |
Hazama Y, Moriya T, Sugihara M, Sano R, Shiota M, Nakamura T, Shimoya K. The Analysis of Cell Cycle-related Proteins in Ovarian Clear Cell Carcinoma Versus High-grade Serous Carcinoma. Int J Gynecol Pathol 2018;37:516-24. [PMID: 29019869 DOI: 10.1097/PGP.0000000000000461] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 10 |
Pyo JS, Kim NY. Meta-analysis of prognostic role of Ki-67 labeling index in gastric carcinoma. Int J Biol Markers 2017;32:e447-53. [PMID: 28561880 DOI: 10.5301/ijbm.5000277] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 11 |
Zhao H, Wen J, Dong X, He R, Gao C, Zhang W, Zhang Z, Shen L. Identification of AQP3 and CD24 as biomarkers for carcinogenesis of gastric intestinal metaplasia. Oncotarget 2017;8:63382-91. [PMID: 28968998 DOI: 10.18632/oncotarget.18817] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 12 |
Xing Y, Wang C, Wu J. Expression of geminin, p16, and Ki67 in cervical intraepithelial neoplasm and normal tissues. Medicine (Baltimore) 2017;96:e7302. [PMID: 28658133 DOI: 10.1097/MD.0000000000007302] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 13 |
Kushwaha PP, Rapalli KC, Kumar S. Geminin a multi task protein involved in cancer pathophysiology and developmental process: A review. Biochimie 2016;131:115-27. [PMID: 27702582 DOI: 10.1016/j.biochi.2016.09.022] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 14 |
Tökés A, Szász AM, Geszti F, Lukács LV, Kenessey I, Turányi E, Meggyesházi N, Molnár IA, Fillinger J, Soltész I, Bálint K, Hanzély Z, Arató G, Szendröi M, Kulka J. Expression of proliferation markers Ki67, cyclin A, geminin and aurora-kinase A in primary breast carcinomas and corresponding distant metastases. J Clin Pathol 2015;68:274-82. [DOI: 10.1136/jclinpath-2014-202607] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 15 |
Bologna-Molina R, Bedoya-Borella AM, Soria-Moreira L, Soría-Suárez S. Molecular biomarkers of cell proliferation in ameloblastomas. World J Stomatol 2013; 2(4): 79-85 [DOI: 10.5321/wjs.v2.i4.79] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 16 |
Kimura F, Okayasu I, Kakinuma H, Satoh Y, Kuwao S, Saegusa M, Watanabe J. Differential diagnosis of reactive mesothelial cells and malignant mesothelioma cells using the cell proliferation markers minichromosome maintenance protein 7, geminin, topoisomerase II alpha and Ki-67. Acta Cytol 2013;57:384-90. [PMID: 23860238 DOI: 10.1159/000350262] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 17 |
Kapoor S. Emerging role of geminin as a prognostic marker in systemic malignancies. J Breast Cancer 2012;15:481. [PMID: 23346181 DOI: 10.4048/jbc.2012.15.4.481] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 18 |
He WL, Li YH, Yang DJ, Song W, Chen XL, Liu FK, Wang Z, Li W, Chen W, Chen CY. Combined evaluation of centromere protein H and Ki-67 as prognostic biomarker for patients with gastric carcinoma. Eur J Surg Oncol. 2013;39:141-149. [PMID: 22999412 DOI: 10.1016/j.ejso.2012.08.023] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 19 |
Di Bonito M, Cantile M, Collina F, Scognamiglio G, Cerrone M, La Mantia E, Barbato A, Liguori G, Botti G. Overexpression of Cell Cycle Progression Inhibitor Geminin is Associated with Tumor Stem-Like Phenotype of Triple-Negative Breast Cancer. J Breast Cancer 2012;15:162-71. [PMID: 22807933 DOI: 10.4048/jbc.2012.15.2.162] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
|
